An overall trend of dose-dependent increase was only found in the +1 frameshift mutations, suggesting a potential treatment-related effect.
← all excerpts
Subchronic perfluorooctanesulfonate (PFOS) exposure induces elevated mutant frequency in an in vivo λ transgenic medaka mutation assay.
1
—
—